CORRIDOR INFORMATION DOCUMENT

CID provides all information you need about Rail Freight Corridor Orient/East-Med, such as legal background, infrastructure characteristics, access conditions, description of terminals along the route, capacity allocation and traffic management processes.

CID applies the RNE CID Common Texts and Structure so that all applicants can access similar documents along different corridors and in principle, as is the case with national Network Statements, find the same information at the same place in each one.

CID for timetable 2025 can be found below (last updated: 08-01-2024):

• CID Sections 1-4 (pdf)
  • Annex 4A Framework for Capacity Allocation (pdf)
• Implementation Plan (pdf)
  • Annex 1 MoU Establishing the Executive Board (pdf)
  • Annex 2 MoU Establishing the Management Board (pdf)
  • Annex 3 Letters of Intent of Advisory Groups (zip)
  • Annex 4 Rules of AG Consultation (pdf)
  • Annex 5 Transport Market Study (pdf)
  • Annex 6 Investment Plan (pdf)
  • Annex 7 RFC 7 C-OSS Operational Rules for timetable 2025
  • Annex 8 General objectives

CID for timetable 2024 can be found below (last updated: 08-01-2024):

• CID Sections 1-4 (pdf)
  • Annex 4A Framework for Capacity Allocation (pdf)
• Implementation Plan (pdf)
  • Annex 1 MoU Establishing the Executive Board (pdf)
  • Annex 2 MoU Establishing the Management Board (pdf)
  • Annex 3 Letters of Intent of Advisory Groups (zip)
  • Annex 4 Rules of AG Consultation (pdf)
  • Annex 5 Transport Market Study (pdf)
  • Annex 6 Investment Plan (pdf)
  • Annex 7 RFC 7 C-OSS Operational Rules for timetable 2024

RailNetEurope provides a glossary for the terms related to the network statements and the Corridor Information Document.
The glossary can be downloaded from the following page: https://rne.eu/organisation/network-statements/  

Archives

Corridor Information Document versions from past timetable years can be downloaded by clicking on the links below. Documents not having been amended between timetable years are displayed in merged cells.